Nuclear Medicine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
Conditions:   Bone Loss;   Muscle Atrophy;   Bariatric Surgery Interventions:   Drug: Zoledronic Acid;   Drug: Placebo Sponsors:   Stinus Gadegaard Hansen;   Research Unit of Health Sciences, Hospital of South West Jutland;   Department of Regional Health Research, University of Southern Denmark;   OPEN - Odense Patient data Explorative Network, The University of Southern Denmark, Odense, Denmark;   Department of Radi ology and Nuclear Medicine, Hospital of Southwest Jutland, 6700 Esbjerg, Denmark;   Department of Endocrinology, Odense University Hospital, Odense, Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2021 Category: Research Source Type: clinical trials